Series B Round
Funding Details
Azafaros is a biotechnology company focused on developing innovative therapies for rare diseases, leveraging advanced technologies to improve patient outcomes. The company aims to address unmet medical needs by utilizing cutting-edge research and development methodologies. Azafaros is committed to advancing the field of biotechnology through its proprietary platforms and collaborations with leading research institutions.
Confidence Score
Participating Investors
No investors recorded for this funding round.
Related Tweets
No tweets found for this funding round.